Purpose : To assess the viability of frozen-thawed embryos derived from intracytoplasmic sperm injection (ICSI) in azoospermic men. Methods : Retrospective analysis of 154 consecutive ICSI cycles using surgically retrieved sperm from azoospermic men and case-control comparison of subsequent frozen transfer cycles with those using embryos generated from ejaculated sperm. Results : Patient and fresh cycle characteristics were similar in both groups. There were no differences between the two groups in the proportion of pronucleate (54% and 62%), and cleavage-stage embryos thawed (46% and 38%), post-thaw survival rates (retrievals: 69%; ejaculated: 73%) or quality of frozen embryos subsequently transferred. Implantation was significantly lower in frozen cycles where embryos were generated from surgically retrieved sperm (0% versus 11.5%; p = 0.03). Both clinical pregnancy rate (5% versus 21%) and livebirth rate (0% versus 21%) were lower in this group, but only the difference in LBR reached borderline statistical difference ( p = 0.10). Conclusion : This small series demonstrates a significant impairment in implantation in FET cycles using embryos generated from surgically retrieved sperm and a trend towards a poorer pregnancy outcome.
INTRODUCTION
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male factor fertility, with Palermo et al. (1) reporting the first pregnancies and livebirths after ICSI in four women who had not benefited from IVF or subzonal sperm injection (SUZI). The ability of ICSI to achieve high fertilisation and pregnancy rates regardless of semen parameters (2) led to its application in azoospermic patients. Studies have reported significantly lower fertilisation with the use of surgically retrieved sperm in comparison to ejaculated samples (ejaculated: 70%; epididymal: 56%; testicular: 48%) (3) (4) (5) . Although implantation (ejaculated: 26%; testicular:13%) (6) and pregnancy outcome (ejacu1ated: 21%; epididymal: 22%: testicular: 10%) (7) have been reported to be significantly lower, this was found only in cases where sperm was obtained from non-obstructive azoospermic men. In studies of only men with nonobstructive azoospermia, impaired fertilisation has been confirmed (ejaculated: 56.9%; non-obstructive: 37.7%) (8) .
Overall, the majority of large series of ICSI cycles from azoospermic men, using both fresh and cryopreserved sperm and from either obstructive or non-obstructive cases of azoospermia have reported excellent fertilisation (56-81%) and clinical pregnancy outcome (24-37% per embryo transfer) (9) (10) (11) (12) (13) (14) (15) .
Embryo cryopreservation is now a well-established technique that allows the storage of supernumerary embryos created during assisted reproductive techniques (ART). Although an early report raised concerns that pregnancies from cryopreserved-thawed embryos derived from ICSI may carry an increased risk of pregnancy loss (16) , later studies showed similar pregnancy (16-32% and 16-52%) and delivery rates (15-27% and 20-52%) in IVF and ICSI derived embryos respectively (17) (18) (19) (20) (21) . However, there is little in the literature assessing the outcome of FET cycles from embryos generated following ICSI using surgically retrieved sperm from azoospermic men. In the only study that reported fresh and FET cycles from a cohort of patients with non-obstructive azoospermia (22) , they reported clinical pregnancy and implantation rates of 36% and 13% respectively and postthaw survival, clinical pregnancy and implantation rates of 68%, 24% and 8% respectively in the 17 FET cycles.
The aims of this retrospective analysis was (i) to present the results of a series FET cycles from embryos derived from ICSI cycles in azoospermic men and (ii) to compare these results with those from a matched control group.
MATERIALS AND METHODS
This retrospective analysis involved 154 consecutive ICSI cycles performed between November 1996 and July 2002 (from 91 couples) using surgically retrieved sperm in patients with either obstructive or non-obstructive azoospermia. From these cycles, good-quality supernumerary embryos were cryopreserved at the pronucleate or cleavage stage. FET cycles were subsequently performed at the request of the couples (Group 1).
An age-matched and embryo-quality (at embryo transfer) matched group was selected from all frozen embryo transfer cycles performed that followed fresh ICSI cycles using ejaculated sperm in our unit over a similar time period (Group 2).
Sperm Retrieval and Assisted Reproduction
In all cases, surgical sperm retrieval was performed by the same surgeon. Epididymal sperm was retrieved by microsurgical sperm aspiration (MESA) under general anaesthesia. The samples were prepared in the IVF laboratory by washing in 1-2 mL of culture medium. The suspension was centrifuged at 1000 rpm for 10 min and the pellet redispersed in 50-100 µL of culture medium. Presence of motile sperm was assessed under an inverted microscope (×400 magnification, Hoffman modulation). The prepared samples were left in the incubator, set at 37
• in an atmosphere of 5% CO 2 in air, until use. In cases where no motile sperm were found in the MESA sample, a testicular biopsy was performed (TESE). The tubules were minced using two insulin-needles and sterile glass slides, and sperm suspension prepared as described above. Epididymal or testicular sperm suspension was pipetted into microdrops of culture medium under paraffin oil. Under the inverted microscope, a motile sperm was immobilised using a microinjecting pipette and placed into polyvinylpyrolidone drop (PVP; Medicult, U.K.) prior to ICSI.
For fresh ejaculated semen, samples were allowed to liquefy at room temperature for approximately 20 min. The samples were either washed with culture media as described earlier or a two-layer density gradient (45% and 90%; Puresperm, Nicadon, Sweden) was used. Following centrifugation at 1000 rpm for 20 min, the pellet was washed twice in culture medium and the final pellet resuspended in approximately 100 µL of medium.
For retrieved sperm, surplus spermatozoa were cryopreserved for future ICSI attempts, thus avoiding the need for repeated microsurgery. The sperm suspension was diluted with an equal volume of sperm cryopreservation medium (Medicult, U.K.), aliquoted into cryovials and suspended in liquid nitrogen vapour for 30 min before being submerged in liquid nitrogen for storage. On the morning of oocyte retrieval, a vial of frozen sample was thawed at room temperature for 20 min. Samples were subsequently prepared as described earlier.
Oocyte retrieval was performed after pituitary desensitisation with gonadotrophin-releasing hormone agonists (long protocol) and ovulation stimulation with gonadotrophins. The oocytes were stripped of surrounding cumulus cells using hyaluronidase (Medicult, U.K.) and ICSI performed between 38-42 h post human chorionic gonadotrophin (hCG) injection. Fertilisation was assessed 16-18 h post ICSI, and top quality embryos were subsequently transferred on either Day 2 (cleaved to the 2-to 4-cell stage by 42-49 h post injection) or Day 3 (cleaved to the 5-to 8-cell stage by 64-72 h post injection) post oocyte retrieval. Luteal support was administered in the form of progesterone pessaries (800 mg/day; Cyclogest  ; Shire Pharmaceuticals, Basingstoke, U.K.) from the day of transfer and continued until the twelfth week of pregnancy where appropriate.
Embryo Cryopreservation
Embryos were cryopreserved at the pronucleate or cleavage stage (2-to 8-cell), in 1,2-propanediol (PROH) and sucrose as the cryoprotectants using the slow cooling method. The medium for preparation of the cryoprotectant and the sucrose solutions is phosphate-buffered saline (PBS) containing 20% human serum albumin (HSA). Embryos were incubated at room temperature in a mixture of 1.5 M PROH and HSA for 10 min before being transferred to a solution containing 1.5 M PROH, 0.1 M sucrose and HSA, and loaded into straws. Cooling was performed using a biological programmable cell freezer (Kryo 10 Series II, Planer Products Ltd) with liquid nitrogen vapour. Embryos were cooled initially to −7
• C at a rate of −2
• C/min, where seeding was performed using forceps, after which they were cooled to −30
• C at a rate of −0.3 • C/min, then to −150 • C at a rate of −10
• C/min. The straws were finally plunged into liquid nitrogen at −196
• C for storage.
Embryo Thawing
Embryos were thawed using the rapid thaw method by a four-step process to remove the cryoprotectants; pronucleate and cleavage stage embryos were thawed one day prior to and same day of FET respectively. Straws were removed from liquid nitrogen and incubated at room temperature for 40 s before incubating for 5 min in thawing media containing a mixture of PROH, sucrose and HSA. Thawed embryos were subsequently washed and rehydrated in pre-equilibrated culture media and incubated for either 24 h (for pronucleate stage embryos) or 3-4 h (for cleavage stage embryos) at 37
• C in an atmosphere of 5% CO 2 in air prior to FET.
Pregnancy was detected using urinary or serum beta HCG tests and clinical pregnancy determined by observation of a gestational sac at a six-week ultrasound scan. Implantation rate was defined as the number of gestation sacs observed divided by the number of embryos transferred.
Statistical analysis was performed using Fisher's exact test and Mann-Whitney U tests.
RESULTS
Of the 154 ICSI cycles commenced, 64 used fresh sperm and 90 cryopreserved sperm. 127 used sperm retrieved from the epididymis and 27 from the testicle. The aetiology of azoospermia was a combination of obstructive (127 cycles) and non-obstructive azoospermia (25 cycles) with insufficient data to correctly classify a further two cycles.
137 of 154 cycles proceeded to embryo transfer (89%). From these 25 yielded supernumerary embryos that were suitable for cryopreservation.
To date, 19 FET cycles have been performed in 10 couples where a total of 71 embryos (38 zygotes and 33 cleavage stage) were thawed. Details of the fresh cycles from which these FET cycles ensued can be seen in Table I.  Table II indicates the patient characteristics and fertilization outcome for the fresh ICSI cycles (from azoospermic men and control group) from which supernumerary embryos were later used. Mean paternal (37.9:37.4) and maternal age (33.2:33.6) were similar between the two groups. Maternal serum FSH levels and, in consequence total dose of gonadotrophins required were slightly higher in the ejaculated sperm group (7.4 IU/L and 2313 IU: 6.3 IU/L and 2118 IU). The mean number of eggs collected was similar (18.2: 17.5), although the fertilization rate (FR) was higher in the group using ejaculated sperm (72% versus 59%). Despite this a similar number of embryos were transferred per cycle in the two groups (2.53 and 2.50).
The pregnancy outcome of the fresh cycles is shown in Table III . Similar clinical pregnancy (CPR: 29% versus 25%) and livebirth rates (LBR: 14% versus 19%) per transfer were seen for the retrieved and ejaculated group respectively. The retrieval group (Group 1) had a higher implantation rate (IR) than the ejaculated group (18% versus 10%), although this did not reach clinical significance. This difference can be explained by a triplet pregnancy in this group, where selective reduction was performed, but led to miscarriage of all three fetuses. The numbers of embryos frozen per treatment cycle were similar at 4.9 and 6.1 for the retrieved and ejaculated group respectively. The pregnancy outcome of the 19 FET cycles from embryos cryopreserved from the fresh cycles outlined above can be seen in Table IV . There were no differences between the two groups in the proportion of pronucleate (54% and 62%), and cleavage-stage embryos thawed (46% and 38%). Furthermore, postthaw survival rates (retrievals: 69%; ejaculated: 73%), and quality of embryos subsequently transferred at FET were comparable. The mean number of embryos transferred was higher in Group 2 (2.74 versus 2.32) but this was of borderline statistical significance ( p = 0.08). Implantation rate was significantly lower in FET cycles using embryos generated from surgically retrieved sperm compared to those from ejaculated sperm (0% versus 11.5%: p = 0.03). Both CPR (5% versus 21%) and LBR (0% versus 21%) were also lower but only the difference in LBR reached borderline statistical difference ( p = 0.10). This clinical pregnancy rate of 21.1% for Group 2 is similar to the overall rate from all FET cycles in our unit over the time period of this study of 18.7%.
DISCUSSION
To our knowledge, this is the first report that compares the viability of frozen embryos generated from ICSI cycles using either ejaculated or surgically retrieved sperm. The data demonstrate impaired implantation and a trend towards a poorer pregnancy In our report, the maternal age was matched between groups 1 and 2, and the fresh cycles from which the embryos were cryproserved had a comparable number of oocytes collected, comparable pregnancy outcome and a similar proportion of embryos available for cryopreservation (Tables II and III) . The only factor discrepant between the groups was the mean number of embryos transferred at FET (2.32 and 2.74 for retrieved and ejaculated sperm respectively), which was of borderline significance ( p = 0.08).
The first report of FET cycles from ICSIgenerated embryos using surgically retrieved sperm for injection (frozen testicular sperm from nonobstructive azoospermic patients) was published in 1999 (22) . From a total of 17 FET cycles analysed, the authors reported a CPR, ongoing pregnancy rate and IR of 23%, 17% and 8% respectively. Unlike our report, the fresh cycles from which these embryos were cryopreserved were not separately assessed (FR, IR and CPR of 59%, 18% and 29% respectively in our patient group).
The data presented in this study of FET cycles by source of sperm suggests significantly impaired clinical outcome with the use of frozen-thawed ICSIgenerated embryos where surgically retrieved sperm from azoospermic men was used. The origin of the sperm appears to be a major contributory factor since the two groups were matched for maternal age and FSH, mean number of oocytes collected and embryos transferred at fresh cycle, outcome of fresh cycle and post-thaw survival. One possible explanation for the poorer clinical outcome is that such embryos, originating from suboptimal sperm, are potentially associated with higher levels of faulty DNA (28) . This in turn, may render them more susceptible to cryodamage thus compromising their viability.
CONCLUSIONS
In view of the small numbers of FET cycles performed following ICSI using surgically retrieved sperm, these findings need to be confirmed in larger multi-center studies. Further studies are also needed to assess the impact of source of sperm (i.e. epididymal or testicular), aetiology of azoospermia (i.e. obstructive or non-obstructive) and use of fresh versus frozen sperm on FET outcome. If these findings are confirmed, counseling of couples embarking on ICSI cycles using surgically retrieved sperm from azoospermic men will have to include the poorer outcome of such FET cycles.
